Published in FDA Law Weekly, September 24th, 2009
The FDA grants orphan drug designation to drugs that may provide a significant therapeutic advantage over...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.